【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 16
2 Introduction 17
2.1 Prosthetic Heart Valves Overview 17
3 Products under Development 18
3.1 Prosthetic Heart Valves – Pipeline Products by Stage of Development 18
3.2 Prosthetic Heart Valves – Pipeline Products by Segment 19
3.3 Prosthetic Heart Valves – Pipeline Products by Territory 20
3.4 Prosthetic Heart Valves – Pipeline Products by Regulatory Path 21
3.5 Prosthetic Heart Valves – Pipeline Products by Estimated Approval Date 22
3.6 Prosthetic Heart Valves – Ongoing Clinical Trials 23
4 Prosthetic Heart Valves – Pipeline Products under Development by Companies 24
4.1 Prosthetic Heart Valves Companies – Pipeline Products by Stage of Development 24
4.2 Prosthetic Heart Valves – Pipeline Products by Stage of Development 27
5 Prosthetic Heart Valves Companies and Product Overview 31
5.1 Aegis Surgical Limited Company Overview 31
5.1.1 Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview 31
5.2 AorTech International plc Company Overview 32
5.2.1 AorTech International plc Pipeline Products & Ongoing Clinical Trials Overview 32
5.3 Apica Cardiovascular Limited Company Overview 34
5.3.1 Apica Cardiovascular Limited Pipeline Products & Ongoing Clinical Trials Overview 34
5.4 Boston Children’s Hospital Company Overview 35
5.4.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 35
5.5 Boston Scientific Corporation Company Overview 37
5.5.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
5.6 Braile Biomedica Ltda. Company Overview 46
5.6.1 Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview 46
5.7 Caisson Interventional, LLC Company Overview 48
5.7.1 Caisson Interventional, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.8 Cardiac Dimensions, Inc. Company Overview 49
5.8.1 Cardiac Dimensions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.9 CardiAQ Valve Technologies, Inc. Company Overview 53
5.9.1 CardiAQ Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.10 Cardio3 BioSciences SA Company Overview 59
5.10.1 Cardio3 BioSciences SA Pipeline Products & Ongoing Clinical Trials Overview 59
5.11 Cephea Valve Technologies, Inc. Company Overview 60
5.11.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.12 Clemson University Company Overview 61
5.12.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 61
5.13 Colibri Heart Valve, LLC Company Overview 62
5.13.1 Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 CorMatrix Cardiovascular, Inc. Company Overview 70
5.14.1 CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.15 CryoLife, Inc. Company Overview 75
5.15.1 CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.16 Cytograft Tissue Engineering, Inc. Company Overview 77
5.16.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.17 Direct Flow Medical, Inc. Company Overview 78
5.17.1 Direct Flow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.18 Dura Biotech Company Overview 83
5.18.1 Dura Biotech Pipeline Products & Ongoing Clinical Trials Overview 83
5.19 Edwards Lifesciences Corporation Company Overview 85
5.19.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 85
5.20 Emory University Company Overview 106
5.20.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 106
5.21 HighLife SAS Company Overview 108
5.21.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview 108
5.22 HLT, Inc. Company Overview 109
5.22.1 HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109
5.23 Innovia LLC Company Overview 112
5.23.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 112
5.24 JenaValve Technology GmbH Company Overview 115
5.24.1 JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 115
5.25 Leman Cardiovascular Company Overview 120
5.25.1 Leman Cardiovascular Pipeline Products & Ongoing Clinical Trials Overview 120
5.26 Mayo Clinic Company Overview 121
5.26.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 121
5.27 Medi-Line S.A. Company Overview 122
5.27.1 Medi-Line S.A. Pipeline Products & Ongoing Clinical Trials Overview 122
5.28 Medtronic plc Company Overview 123
5.28.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 123
5.29 Meril Life Sciences Pvt. Ltd. Company Overview 135
5.29.1 Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 135
5.30 Micro Interventional Devices, Inc. Company Overview 136
5.30.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.31 MicroPort Scientific Corporation Company Overview 138
5.31.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 138
5.32 Mitralix Ltd. Company Overview 142
5.32.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 142
5.33 MitrAssist Ltd. Company Overview 143
5.33.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview 143
5.34 Mitricares Company Overview 144
5.34.1 Mitricares Pipeline Products & Ongoing Clinical Trials Overview 144
5.35 NaviGate Cardiac Structures, Inc. Company Overview 145
5.35.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 145
5.36 Neovasc Inc. Company Overview 146
5.36.1 Neovasc Inc. Pipeline Products & Ongoing Clinical Trials Overview 146
5.37 Peca Labs, Inc. Company Overview 150
5.37.1 Peca Labs, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.38 PolyNova Cardiovascular LLC Company Overview 151
5.38.1 PolyNova Cardiovascular LLC Pipeline Products & Ongoing Clinical Trials Overview 151
5.39 RegenaGraft Company Overview 152
5.39.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 152
5.40 Revivicor, Inc. Company Overview 153
5.40.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 153
5.41 SAS Cormove Company Overview 154
5.41.1 SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview 154
5.42 Scientific and Production Center Amphion, LLC Company Overview 155
5.42.1 Scientific and Production Center Amphion, LLC Pipeline Products & Ongoing Clinical Trials Overview 155
5.43 Sorin S.p.A. Company Overview 156
5.43.1 Sorin S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 156
5.44 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 160
5.44.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 160
5.45 St. Jude Medical, Inc. Company Overview 162
5.45.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 162
5.46 Stellenbosch University Company Overview 175
5.46.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 175
5.47 Strait Access Technologies (Pty) Ltd Company Overview 176
5.47.1 Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 176
5.48 Symetis AG Company Overview 178
5.48.1 Symetis AG Pipeline Products & Ongoing Clinical Trials Overview 178
5.49 Tendyne Medical, Inc. Company Overview 184
5.49.1 Tendyne Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.50 The Tel Aviv Sourasky Medical Center Company Overview 187
5.50.1 The Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 187
5.51 Thubrikar Aortic Valve, Inc. Company Overview 188
5.51.1 Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 188
5.52 Tissue Regenix Ltd Company Overview 190
5.52.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 190
5.53 Transcatheter Technologies GmbH Company Overview 193
5.53.1 Transcatheter Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 193
5.54 Twelve, Inc Company Overview 196
5.54.1 Twelve, Inc Pipeline Products & Ongoing Clinical Trials Overview 196
5.55 UMC Utrecht Holding BV Company Overview 197
5.55.1 UMC Utrecht Holding BV Pipeline Products & Ongoing Clinical Trials Overview 197
5.56 University College London Company Overview 198
5.56.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 198
5.57 University of California, Irvine Company Overview 199
5.57.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 199
5.58 University of Pennsylvania Company Overview 202
5.58.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 202
5.59 Valtech Cardio Ltd. Company Overview 204
5.59.1 Valtech Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview 204
5.60 ValveXchange, Inc. Company Overview 205
5.60.1 ValveXchange, Inc. Pipeline Products & Ongoing Clinical Trials Overview 205
5.61 VueKlar Cardiovascular Ltd. Company Overview 208
5.61.1 VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 208
5.62 Xeltis AG Company Overview 210
5.62.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 210
6 Prosthetic Heart Valves- Recent Developments 211
7 Appendix 306
7.1 Methodology 306
7.2 About GlobalData 308
7.3 Contact Us 309
7.4 Disclaimer 309
【レポート販売概要】
■ タイトル：人工心臓弁の世界市場：パイプラインレビュー2015■ 英文：Prosthetic Heart Valves - Pipeline Review, 2015
■ 発行日：2015年4月28日
■ 調査会社：GlobalData
■ 商品コード：GDME0006EPD
■ 調査対象地域：グローバル
- 世界のNCCM（Network Configuration and Change Management）市場動向、技術進歩、予測及び分析(2014 – 2019)NCCM is a network management tool that enables the enterprises to control and monitor the performance of their network infrastructure. It helps to improve the performance and efficiency of the network, manage remotely located devices, reduce time required to configure heterogeneous networks, reduce losses due to downtime, and reduce IT expenditure. The Network Configuration and Change Management ( …
- 海軍戦闘システムの世界市場2017-2021About naval combat systemsA naval combat system is an integrated system for naval vessels that are fitted with command and control, communication, surveillance, and firearm-launching equipment. Technavio’s analysts forecast the global naval combat systems market to grow at a CAGR of 3.48% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth pr …
- 脊椎用インプラント/デバイスの世界市場：胸部融合デバイス、腰部融合デバイス、頸部融合デバイス、脊椎用生物製剤、圧迫骨折治療デバイス、骨刺激装置The global spinal implants and spinal devices market is estimated to grow at a CAGR of 5.6% from 2015 to 2020. Although mature markets (such as North America and Europe) hold larger shares in the spinal implants and spinal devices market in 2015, the Asia-Pacific region is poised to grow at the highest CAGR of 8.2% in the next five years. Factors such as the presence of a large patient population, …
- アメリカの不妊治療市場2016-2020About Fertility Couples with fertility issues are unable to conceive even after regular unprotected coitus (six months if the woman is over age 35). Female or male infertility factors account for one-third of the cases, where a couple is unable to conceive. In the rest of the cases, the cause is either unknown or a combination of both male and female infertility factors. In males, low sperm produc …
- Madalena Ventures Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Madalena Ventures Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Madalena Ventures Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 世界のプレハブ式ビル市場における動向と市場機会（～2017）In terms of growth, the global prefabricated buildings market recorded a review-period (2008?2012) CAGR of 1.92%. The growth was subdued by a 15% decline in the market in 2009, due to the financial crisis. Construction activity slowed, and consequently the demand for prefabricated buildings declined. The market is expected to record a forecast-period CAGR of 8.59% due to construction industry grow …
- 世界のサービスデリバリプラットフォーム市場In the current telecom industry, stiff competition has resulted in a decrease in profit margins for service providers. To counter this, service providers are constantly developing innovative business models. Also, the immense popularity of web apps by web based application providers, such as Google and Yahoo, has fuelled the growth of SDP implementation by the MNO’s for rolling out their own app s …
- 世界のオフハイウェイタイヤ市場動向：Global Off-highway Tire Market 2014-2018TechNavio's analysts forecast the Global Off-highway Tire market to grow at a CAGR of 4.50 percent over the period 2014-2018. One of the key factors contributing to this market growth is the growing Global Heavy Construction Equipment market. The Global Off-highway Tire market has also been witnessing the increasing demand for off-highway tires from BRIC countries. However, the increase in the raw …
- 大気造水（AWG）の世界市場分析：製品別（冷却凝縮、湿潤乾燥）、用途別（産業、商業、住居）、セグメント予測The global AWG market is expected to reach USD 4.74 billion by 2024, according to a new report by Grand View Research, Inc. Increasing installations of AWG at commercial places such as banks, educational institutes, and municipal agencies is anticipated to have a positive impact on the industry growth over the next eight years. Atmospheric water generator requirements for industrial and commercial …
- 世界のニードルコークス市場2015The Global Needle Coke Industry Report 2015 is a professional and in-depth study on the current state of the Needle Coke industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Needle Coke market analysis is provided for the international markets including development trends, competitive landscape analysis …
- 世界の化学品流通市場動向（2012-2016）TechNavio's analysts forecast the Global Chemical Distribution market to grow at a CAGR of 9.69 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing economic growth in the APAC region. The Global Chemical Distribution market has also been witnessing an increase in the number of mergers and acquisitions. However, regulatory challenges could …
- モバイルVoIPの世界市場2016-2020About the Mobile Voice Over Internet Protocol (VoIP) Market VoIP functions on broadband networks using packet switched telephone networks (PSTNs), unlike traditional calls on circuit switched networks. PSTNs are more efficient than legacy systems (circuited switched networks), and information can be routed in packets over optimized paths. Mobile VoIP allows IP calls over mobile networks (3G/LTE) o …
- ブラジルの心臓人工弁市場見通し（～2021）Brazil Prosthetic Heart Valve Procedures Outlook to 2021 Summary GlobalData’s new report, "Brazil Prosthetic Heart Valve Procedures Outlook to 2021", provides key procedures data on the Brazil Prosthetic Heart Valve Procedures. The report provides procedure volumes within market segments - Conventional Aortic Valve Replacement Procedures, Conventional Mitral Valve Procedures and Transcatheter Hear …
- 転移性乳癌：世界の臨床試験レビュー（2014年上半期）Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Breast Cancer. It includes an overview of the trial num …
- 2014年戦略提言：ヨーロッパの免疫タンパク質検査市場This new 273-page report from Venture Planning Group provides analysis of the European immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the follow assays:C3C4Free Light ChainsHaptoglobinIgAI …
